Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Michelle Dehoorne"'
Publikováno v:
Critical Care Medicine. 51:391-391
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0108dba71059af38c9672b5f2b0bae5
https://doi.org/10.1097/01.ccm.0000908928.26980.03
https://doi.org/10.1097/01.ccm.0000908928.26980.03
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 77(Supplement_4)
Purpose To evaluate the impact of a newly implemented clinical decision support (CDS) tool targeting QT interval–prolonging medications on order verification and provider interventions. Methods A multicenter, retrospective quasi-experimental study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2eec83b314efed4479485dfeb5f01f3
https://pubmed.ncbi.nlm.nih.gov/32839818
https://pubmed.ncbi.nlm.nih.gov/32839818
Autor:
Michelle Dehoorne-Smith, Stephanie B. Edwin, Katie Chernoby, Carrie Hartner, Michael F. Lucey
Publikováno v:
Critical Care Medicine. 48:628-628
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7dedf593ac535525018a36a7208f4cfb
https://doi.org/10.1097/01.ccm.0000645128.56761.01
https://doi.org/10.1097/01.ccm.0000645128.56761.01
Publikováno v:
The Canadian journal of hospital pharmacy. 69(5)
Background: Methicillin-resistant Staphylococcus aureus is a leading cause of death in patients undergoing hemodialysis. However, controversy exists about the optimal dose of vancomycin that will yield the recommended pre-hemodialysis serum concentra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ac82e67f491f6e1fe8d88130d8ea5a8
https://pubmed.ncbi.nlm.nih.gov/27826151
https://pubmed.ncbi.nlm.nih.gov/27826151
Publikováno v:
Critical Care Medicine. 40:1-328
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3db33ad04c26f1dd8b0cd5529f4f992
https://doi.org/10.1097/01.ccm.0000425160.63208.3d
https://doi.org/10.1097/01.ccm.0000425160.63208.3d
Publikováno v:
Critical Care Medicine. 40:1-328
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::109679629f052cb418996c5d9b413851
https://doi.org/10.1097/01.ccm.0000425173.57370.fa
https://doi.org/10.1097/01.ccm.0000425173.57370.fa
Publikováno v:
Critical Care Medicine. 40:1-328
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03470d6bce2bcf3b0d1cde602badab75
https://doi.org/10.1097/01.ccm.0000424311.32952.b6
https://doi.org/10.1097/01.ccm.0000424311.32952.b6
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 70(8)
Cardiovascular disease is a significant cause of mortality, accounting for approximately one in every three deaths in the United States.[1][1] The management of sudden cardiac arrest events in a standardized manner comprising early recognition, cardi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf003538d6512b2c41ae3babe5bb63a0
https://pubmed.ncbi.nlm.nih.gov/23552043
https://pubmed.ncbi.nlm.nih.gov/23552043
Publikováno v:
The Canadian Journal of Hospital Pharmacy. 65
Background : The increasing use of vancomycin to treat methicillinresistant Staphylococcus aureus (MRSA) has resulted in reduced susceptibility of MRSA to this drug. It is important to optimize vancomycin dosing in patients who are undergoing hemodia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93a1784962de60aa27b5b17f08365573
https://doi.org/10.4212/cjhp.v65i6.1191
https://doi.org/10.4212/cjhp.v65i6.1191